Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial.

Shuyang Zhang,Ying Li, Xin Xu,Rui Xu, Linchao Zhang, Xiaoqun Wan,Zhuhua Yao,Yuemin Sun, Yong Liu, Jianping Bin,Zhen Wang, Shuren Li,Ping Yang,Xiping Xu, Weidong Liang, Xiaohong Gao, Xiaodong Li, Min Jia, Guang Ma, Xiang Gu, Chang Hong

Frontiers in cardiovascular medicine（2023）

引用 0|浏览6

暂无评分

摘要

Single-pill AML/LOS is superior to LOS monotherapy for controlling BP and is safe and well tolerated in Chinese patients with inadequately controlled hypertension after LOS treatment.

查看译文

关键词

amlodipine besylate, losartan, inadequately controlled hypertension, blood pressure, safety

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要